Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

Burón, Andrea; Grau, J. M.; Andreu, Montserrat; Augé, Josep M.; Guayta-Escolies, Rafael; Barau, Mercè; Macià, Francesc; Castells, Antoni

doi:10.1016/j.medcle.2016.01.019

Cited by 12 publications

(19 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Massive diffusion campaigns are needed to inform the general population about the high frequency of CRC in our setting, its primary risk factors and prevention measures, and the risks and benefits of taking part in screening programmes. The low participation could also be due to the high percentage of people with no education or primary education, comparing with Barcelona (the biggest Catalonian city), which has better participation rates but also lower illiteracy rates 12 23 . Finally, another point to consider for increasing participation rates is the migrant population living in the territory.…”

Section: Discussionmentioning

confidence: 99%

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)

Binefa

Garcia

Milà

et al. 2016

Sci Rep

View full text Add to dashboard Cite

Effective quality assurance is essential in any screening programme. This article provides a unique insight into key quality indicators of five rounds of the first population-based colorectal cancer screening programme implemented in Spain (2000–2012), providing the results according to the type of screening (prevalent or first screen and incident or subsequent screen) and test (guaiac or immunochemical). The total crude participation rate increased from 17.2% (11,011) in the first round to 35.9% (22,988) in the last one. Rescreening rate was very high (88.6% in the fifth round). Positivity rate was superior with the faecal immunochemical test (6.2%) than with the guaiac-based test (0.7%) (p < 0.0001) and detection rates were also better with the immunochemical test. The most significant rise in detection rate was observed for high risk adenoma in men (45.5 per 1,000 screened). Most cancers were diagnosed at an early stage (61.4%) and there was a statistically significant difference between those detected in first or subsequent screening (52.6% and 70.0% respectively; p = 0.024). The availability of these results substantially improves data comparisons and the exchange of experience between screening programmes.

show abstract

Section: Discussionmentioning

confidence: 99%

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)

Binefa

Garcia

Milà

et al. 2016

Sci Rep

View full text Add to dashboard Cite

show abstract

“…In this scenario, learning about how existing comorbidities affect key performance indicators for colorectal cancer screening programmes must be a priority. In the Barcelona Colorectal Cancer Screening Programme (BCCSP), men and women aged 50 to 69 are invited to a FIT every 2 years [ 17 ]. Individuals receive a mailed invitation letter along with an explanatory leaflet.…”

Section: Introductionmentioning

confidence: 99%

Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study

et al. 2017

Self Cite

View full text Add to dashboard Cite

BackgroundThere is controversy regarding how comorbidity impacts on colorectal cancer screening, especially in the context of organised programmes. The aim of this study is to assess the effect of comorbidities on participation in the Barcelona population-based colorectal cancer screening programme (BCCSP).MethodsCross-sectional study carried out in ten primary care centres involved in the BCCSP. Individuals aged 50 to 69, at average risk of colorectal cancer, who were invited to participate in the first round of the faecal immunochemical test-based BCCSP were included (2011–2012). The main variable was participation in the BCCSP. Comorbidity was assessed by clinical risk group status. Other adjusting variables were age, sex, socioeconomic deprivation, visits to primary care, smoking, alcohol consumption and body mass index. Logistic regression models were used to test the association between participation in the programme and potential explanatory variables. The results were given as incidence rate ratios (IRR) and their 95% confidence intervals (CI).ResultsOf the 36,208 individuals included, 17,404 (48%) participated in the BCCSP. Participation was statistically significantly higher in women, individuals aged 60 to 64, patients with intermediate socioeconomic deprivation, and patients with more medical visits. There was a higher rate of current smoking, high-risk alcohol intake, obesity and individuals in the highest comorbidity categories in the non-participation group. In the adjusted analysis, only individuals with multiple minor chronic diseases were more likely to participate in the BCCSP (IRR 1.14; 95% CI [1.06 to 1.22]; p < 0.001). In contrast, having three or more dominant chronic diseases was associated with lower participation in the screening programme (IRR 0.76; 95% CI [0.65 to 0.89]; p = 0.001).ConclusionsHaving three or more dominant chronic diseases, was associated with lower participation in a faecal immunochemical test-based colorectal cancer screening programme, whereas individuals with multiple minor chronic diseases were more likely to participate. Further research is needed to explore comorbidity as a cause of non-participation in colorectal cancer screening programmes and which individuals could benefit most from colorectal cancer screening.

show abstract

“…14 The uptake rate in the first round for the Colorectal Cancer Screening Program of Barcelona (CCSPB) was 43.6%. 15 Differences in programme organisation, sociodemographics, and primary care professional involvement may explain these differences (for example, the involvement of the GP differs depends on certified training, scheduling of colonoscopy, information feedback, or FIT collection in primary care).…”

Section: Introductionmentioning

confidence: 99%

“…15 Individuals receive a mailed invitation letter, along with an explanatory leaflet about colorectal cancer, screening, and the specific programme. The FIT is delivered and collected at the community pharmacies involved in the programme.…”

Section: Introductionmentioning

confidence: 99%

“…Both primary care professionals and pharmacists attended a specific training session at the beginning of each screening round, which explained their role and the functioning of the programme, for example, the standard procedures outlined in the CCSPC. 15 Primary care professionals are encouraged to promote colorectal cancer screening and to help the programme refine the target population by identifying individuals with exclusion criteria.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care

et al. 2016

Self Cite

View full text Add to dashboard Cite

Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

Cited by 12 publications

References 23 publications

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)

Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study

Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care

Contact Info

Product

Resources

About